Soroban Capital Partners’s Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant CPUH.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-669,485
Closed -$6.75M 82
2021
Q1
$6.75M Buy
+669,485
New +$7.04M 0.06% 76

Other funds holding CPUH.U

Soroban Capital Partners's CPUH.U Position: Q2 2021 in Review

Soroban Capital Partners sold out of Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant (CPUH.U) in Q2 2021, closing a stake of 669,485 shares — an estimated $6.75M sold.

Soroban Capital Partners first reported a position in CPUH.U in Q1 2021 and held it in 1 quarter. The position peaked at $6.75M in Q1 2021. 59 funds tracked by Wall St. Rank hold CPUH.U as of Q2 2021.

  • Soroban Capital Partners reported no remaining Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant position as of Q2 2021 after selling out during the quarter.
  • Soroban Capital Partners sold 669,485 Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant shares in Q2 2021, an estimated $6.75M.
  • Soroban Capital Partners first reported a position in Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant in Q1 2021 and held it in 1 quarter.
  • Soroban Capital Partners's Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant position peaked at $6.75M in Q1 2021.
  • 59 funds tracked by Wall St. Rank held Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant as of Q2 2021.

Based on Soroban Capital Partners's 13F filing for Q2 2021, filed 16 Aug 2021.